ArticleJournal of medicinal chemistry2025

Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase.

Thomas P Corner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.